Meridian Biotechnologies Limited - Limited company - abbreviated - 11.6

Meridian Biotechnologies Limited - Limited company - abbreviated - 11.6


03307856 1.4.14 31.3.15 31.3.15 Company accounts Private Limited Company FY true false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure033078562014-03-31033078562015-03-31033078562014-04-012015-03-31033078562013-03-31033078562013-04-012014-03-31033078562014-03-3103307856ns12:England2014-04-012015-03-3103307856ns14:PoundSterling2014-04-012015-03-3103307856ns7:Director12014-04-012015-03-3103307856ns7:OrdinaryShareClass12014-04-012015-03-3103307856ns7:Director22014-04-012015-03-3103307856ns7:Director32014-04-012015-03-3103307856ns7:CompanySecretary2014-04-012015-03-3103307856ns7:RegisteredOffice2014-04-012015-03-3103307856ns7:EntityAccountantsOrAuditors2014-04-012015-03-3103307856ns5:PlantMachinery2014-04-012015-03-3103307856ns7:OrdinaryShareClass12015-03-3103307856ns7:OrdinaryShareClass12014-03-31
REGISTERED NUMBER: 03307856 (England and Wales)














ABBREVIATED UNAUDITED ACCOUNTS

FOR THE YEAR ENDED 31 MARCH 2015

FOR

MERIDIAN BIOTECHNOLOGIES LIMITED

MERIDIAN BIOTECHNOLOGIES LIMITED (REGISTERED NUMBER: 03307856)

CONTENTS OF THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2015










Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 4

MERIDIAN BIOTECHNOLOGIES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2015







DIRECTORS: S P Smyth
S P Temple
J Thomson





SECRETARY: Mrs S C Smyth





REGISTERED OFFICE: 5 West Street
Epsom
Surrey
KT18 7RL





REGISTERED NUMBER: 03307856 (England and Wales)





ACCOUNTANTS: Smith Pearman
Chartered Accountants
Hurst House
High Street
Ripley
Surrey
GU23 6AY

MERIDIAN BIOTECHNOLOGIES LIMITED (REGISTERED NUMBER: 03307856)

ABBREVIATED BALANCE SHEET
31 MARCH 2015

2015 2014
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 2 29,250 31,500
Tangible assets 3 19,219 21,142
48,469 52,642

CURRENT ASSETS
Stocks 86,161 79,433
Debtors 72,164 51,893
Cash at bank 2,021 10,095
160,346 141,421
CREDITORS
Amounts falling due within one year 89,073 96,311
NET CURRENT ASSETS 71,273 45,110
TOTAL ASSETS LESS CURRENT
LIABILITIES

119,742

97,752

CREDITORS
Amounts falling due after more than one
year

70,375

73,542
NET ASSETS 49,367 24,210

CAPITAL AND RESERVES
Called up share capital 4 100 100
Profit and loss account 49,267 24,110
SHAREHOLDERS' FUNDS 49,367 24,210

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

MERIDIAN BIOTECHNOLOGIES LIMITED (REGISTERED NUMBER: 03307856)

ABBREVIATED BALANCE SHEET - continued
31 MARCH 2015


The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 14 September 2015 and were signed on its behalf
by:





S P Smyth - Director


MERIDIAN BIOTECHNOLOGIES LIMITED (REGISTERED NUMBER: 03307856)

NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2015


1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Exemption from preparing a cash flow statement
Exemption has been taken from preparing a cash flow statement on the grounds that the company qualifies as a
small company.

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2008, is being amortised evenly over its estimated useful life of twenty years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Plant and machinery etc - 33% on cost and 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held
under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases
are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to the profit and loss account over the relevant period. The
capital element of the future payments is treated as a liability.

MERIDIAN BIOTECHNOLOGIES LIMITED (REGISTERED NUMBER: 03307856)

NOTES TO THE ABBREVIATED ACCOUNTS - continued
FOR THE YEAR ENDED 31 MARCH 2015


2. INTANGIBLE FIXED ASSETS
Total
£   
COST
At 1 April 2014
and 31 March 2015 45,000
AMORTISATION
At 1 April 2014 13,500
Amortisation for year 2,250
At 31 March 2015 15,750
NET BOOK VALUE

At 31 March 2015 29,250
At 31 March 2014 31,500

3. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 April 2014 24,091
Additions 2,550
At 31 March 2015 26,641
DEPRECIATION
At 1 April 2014 2,949
Charge for year 4,473
At 31 March 2015 7,422
NET BOOK VALUE
At 31 March 2015 19,219
At 31 March 2014 21,142

4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2015 2014
value: £    £   
100 Ordinary £1 100 100